CleveMed Interfaces Its SleepView Technology With ProAct Health Solutions’ Comprehensive Chronic Disease Management System

Nov 21, 2013

CleveMed, a leading Home Sleep Testing (HST) manufacturer, announces the integration between its SleepView web-based technology and ProAct Health Solutions national HST program. The SleepView® Monitor is the market’s smallest and lightest, Type III portable home sleep monitor. It allows patients to be tested for Obstructive Sleep Apnea (OSA) in the comfort, convenience and privacy of their own home. The SleepView web portal provides prescribing physicians with secure, HIPAA compliant online access to sleep study reports generated by board certified sleep physicians and a pathway to initiate various treatments. Home sleep testing utilization is gaining ground because it typically costs a fourth of the cost of traditional laboratory studies.ProAct Health Solutions provides a national program for the management of chronic diseases, such as Obstructive Sleep Apnea. ProAct’s program improves the delivery of chronic care through the use of its proprietary cloud-based solution that integrates population screening, testing, diagnostics, therapy selection treatment initiation, monitoring and compliance. ProAct provides an at-home patient management infrastructure that, until now, was available only for in-hospital acute care.”We are excited to partner with ProAct in their effort to deliver a comprehensive solution for healthcare providers to identify and care for patients with Obstructive Sleep Apnea. Our ability to meet ProAct’s complex needs further demonstrates the sophistication of the SleepView web platform and CleveMed’s agility in this market”, said Kirk Scovill, Director of National Accounts & Strategic Partnerships. “CleveMed’s SleepView product is ideal for accurately diagnosing OSA in the comfort of the patient’s home at dramatically reduced cost. When OSA is successfully identified and managed, the clinical and cost impact of many associated diseases is significantly reduced,” said Scott Adams, ProAct’s COO & President.Sleep apnea is the repeated stoppage of breathing during the night, which can severely disrupt patient’s sleep. Sleep Apnea affects more than 40 million patients and the vast majority of sufferers remain undiagnosed and untreated.

CleveMed is a leader in web-based solutions and miniaturized wireless monitors for sleep disorders. CleveMed has developed a growing range of products including SleepView, web portal, Sapphire™, SleepScout™, and others. CleveMed’s products allow sleep studies to be conducted at home; thus, improving access to diagnosis and delivery of sleep apnea care. CleveMed’s vision is to expand the reach of sleep services today and tomorrow. For more information, please visit (Follow us on CleveMed Blogs, twitter, youtube, LinkedIn, and facebook)

ProAct manages the entire continuum of care for patients with chronic diseases who account for 75% of healthcare costs. Employing a proprietary system-of-systems, ProAct connects advanced medical technologies and best clinical practice protocols into a comprehensive delivery platform. ProAct is perfectly aligned with major changes in healthcare, such as accountable care, medical homes, consumerization of health, patient management of chronic conditions and outcomes-based reimbursement. For more information, please visit

For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720